Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma

A better understanding of human hepatocellular carcinoma (HCC) pathogenesis at the molecular level will facilitate the discovery of tumor-initiating events. Transcriptome sequencing revealed that adenosine-to-inosine (A→I) RNA editing of AZIN1 (encoding antizyme inhibitor 1) is increased in HCC specimens. A→I editing of AZIN1 transcripts, specifically regulated by ADAR1 (encoding adenosine deaminase acting on RNA-1), results in a serine-to-glycine substitution at residue 367 of AZIN1, located in β-strand 15 (β15) and predicted to cause a conformational change, induced a cytoplasmic-to-nuclear translocation and conferred gain-of-function phenotypes that were manifested by augmented tumor-initiating potential and more aggressive behavior. Compared with wild-type AZIN1 protein, the edited form has a stronger affinity to antizyme, and the resultant higher AZIN1 protein stability promotes cell proliferation through the neutralization of antizyme-mediated degradation of ornithine decarboxylase (ODC) and cyclin D1 (CCND1). Collectively, A→I RNA editing of AZIN1 may be a potential driver in the pathogenesis of human cancers, particularly HCC.

[1]  D. Haussler,et al.  UCSC genome browser tutorial. , 2008, Genomics.

[2]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[3]  D. Hanahan,et al.  Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer , 2002, BMC Cancer.

[4]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[5]  C. Kahana,et al.  Degradation of Antizyme Inhibitor, an Ornithine Decarboxylase Homologous Protein, Is Ubiquitin-dependent and Is Inhibited by Antizyme* , 2004, Journal of Biological Chemistry.

[6]  S. Maas,et al.  Molecular diversity through RNA editing: a balancing act. , 2010, Trends in genetics : TIG.

[7]  David O. Morgan,et al.  Principles of CDK regulation , 1995, Nature.

[8]  Ruchi M. Newman,et al.  Antizyme Targets Cyclin D1 for Degradation , 2004, Journal of Biological Chemistry.

[9]  U. Mangold.  Antizyme inhibitor: mysterious modulator of cell proliferation , 2006, Cellular and Molecular Life Sciences CMLS.

[10]  N. Sonenberg,et al.  A cell cycle-dependent internal ribosome entry site , 2000 .

[11]  Lior Pachter,et al.  Sequence Analysis , 2020, Definitions.

[12]  B. Zetter,et al.  Evidence of a Role for Antizyme and Antizyme Inhibitor as Regulators of Human Cancer , 2011, Molecular Cancer Research.

[13]  A. Gallo,et al.  A-to-I RNA editing and cancer: From pathology to basic science , 2008, RNA biology.

[14]  P. Seeburg,et al.  Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs requires distant intronic sequences. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Brenda L Bass,et al.  RNA editing by adenosine deaminases that act on RNA. , 2002, Annual review of biochemistry.

[16]  Cole Trapnell,et al.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.

[17]  M. Marra,et al.  Applications of next-generation sequencing technologies in functional genomics. , 2008, Genomics.

[18]  M. O’Connell,et al.  Down-regulation of RNA Editing in Pediatric Astrocytomas , 2008, Journal of Biological Chemistry.

[19]  Sean P Mullen,et al.  RNA editing: a driving force for adaptive evolution? , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.

[20]  Ryan D. Morin,et al.  Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.

[21]  C. Kahana.  Antizyme and antizyme inhibitor, a regulatory tango , 2009, Cellular and Molecular Life Sciences.

[22]  C. Kahana,et al.  Polyamines regulate the expression of ornithine decarboxylase antizyme in vitro by inducing ribosomal frame-shifting. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. Mikkelsen,et al.  Altered adenosine-to-inosine RNA editing in human cancer. , 2007, Genome research.

[24]  J. Mattick,et al.  RNA editing, DNA recoding and the evolution of human cognition , 2008, Trends in Neurosciences.

[25]  S. Gabriel,et al.  Advances in understanding cancer genomes through second-generation sequencing , 2010, Nature Reviews Genetics.

[26]  G. Church,et al.  Genome-Wide Identification of Human RNA Editing Sites by Parallel DNA Capturing and Sequencing , 2009, Science.

[27]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[28]  M Schrey,et al.  Underediting of glutamate receptor GluR-B mRNA in malignant gliomas , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Malin M. Young,et al.  Predicting conformational switches in proteins , 1999, Protein science : a publication of the Protein Society.

[30]  R. Reenan.  Molecular determinants and guided evolution of species-specific RNA editing , 2005, Nature.

[31]  J. F. Atkins,et al.  Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme , 1995, Cell.

[32]  Ronald A. DePinho,et al.  Hepatocellular carcinoma pathogenesis: from genes to environment , 2006, Nature Reviews Cancer.

[33]  D. Xie,et al.  Association of Vimentin overexpression and hepatocellular carcinoma metastasis , 2004, Oncogene.

[34]  P. Seeburg,et al.  RNA editing of AMPA receptor subunit GluR-B: A base-paired intron-exon structure determines position and efficiency , 1993, Cell.

[35]  K. Münger,et al.  Antizyme, a mediator of ubiquitin-independent proteasomal degradation and its inhibitor localize to centrosomes and modulate centriole amplification , 2008, Oncogene.

[36]  K. Nishikura.  Functions and regulation of RNA editing by ADAR deaminases. , 2010, Annual review of biochemistry.

[37]  Y. Murakami,et al.  A macromolecular inhibitor of the antizyme to ornithine decarboxylase. , 1982, The Biochemical journal.

[38]  Orly Dym,et al.  Crystallographic and biochemical studies revealing the structural basis for antizyme inhibitor function , 2008, Protein science : a publication of the Protein Society.

[39]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[40]  C. Samuel,et al.  Antiviral Actions of Interferons , 2001, Clinical Microbiology Reviews.

[41]  S. Thorgeirsson,et al.  Molecular pathogenesis of human hepatocellular carcinoma , 2002, Nature Genetics.

[42]  Ken Chen,et al.  VarScan: variant detection in massively parallel sequencing of individual and pooled samples , 2009, Bioinform..

[43]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[44]  M. Gerstein,et al.  RNA-Seq: a revolutionary tool for transcriptomics , 2009, Nature Reviews Genetics.

[45]  J. Bartek,et al.  Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression , 1996, Molecular and cellular biology.